SOPHiA GENETICS SA Stock Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Real-time Estimate
Tradegate
04:50:28 03/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | -3.45% |
|
-4.14% | +79.12% |
| 05/08 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 05/08 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
| Market Cap | 717M 619M 583M 531M 993M 67.75B 1B 6.9B 2.68B 34.64B 2.69B 2.63B 114B | P/E 2026 * |
-8.98x | P/E 2027 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 717M 619M 583M 531M 993M 67.75B 1B 6.9B 2.68B 34.64B 2.69B 2.63B 114B | EV / Sales 2026 * |
7.53x | EV / Sales 2027 * | 6.04x |
| Free-Float |
88.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : SOPHiA GENETICS SA
| 1 day | -3.45% | ||
| 1 week | -4.14% | ||
| Current month | -2.80% | ||
| 1 month | +39.56% | ||
| 3 months | +67.07% | ||
| 6 months | +79.12% | ||
| Current year | +79.12% |
| 1 week | 6.7 |  | 7.6 |
| 1 month | 4.92 | | 7.6 |
| Current year | 3.46 | | 7.6 |
| 1 year | 3.34 | | 7.6 |
| 3 years | 2.14 | | 7.6 |
| 5 years | 2.08 | | 7.6 |
| 10 years | 2.08 | | 7.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ross Muken
CEO | Chief Executive Officer | 46 | 01/07/2026 |
George Cardoza
DFI | Director of Finance/CFO | 64 | 05/11/2024 |
Abhimanyu Verma
CTO | Chief Tech/Sci/R&D Officer | - | 10/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jurgi Camblong
CHM | Chairman | 47 | 22/06/2026 |
Vincent Ossipow
BRD | Director/Board Member | 57 | 01/06/2014 |
Troy Cox
CHM | Chairman | 61 | 01/02/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.45% | -4.14% | - | - | 717M | |
| +0.49% | +15.05% | +4.37% | +28.17% | 45.21B | |
| -2.27% | -9.54% | -42.33% | +136.32% | 13.19B | |
| -2.25% | +4.37% | -11.82% | +64.79% | 5.89B | |
| -0.38% | +2.66% | +61.23% | - | 4.39B | |
| +1.71% | -0.31% | - | - | 2.03B | |
| +0.22% | +3.41% | +7.76% | -41.59% | 1.57B | |
| -1.18% | -1.52% | -35.88% | - | 1.11B | |
| +0.49% | -1.25% | +34.16% | +151.23% | 1.01B | |
| -4.29% | -5.71% | +48.59% | +60.80% | 1.04B | |
| Average | -1.09% | -1.24% | +8.26% | +66.62% | 8.38B | |
| Weighted average by Cap. | -0.34% | +6.52% | -1.42% | +53.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95.23M 82.16M 77.39M 70.51M 132M 9B 133M 916M 356M 4.6B 358M 350M 15.11B | 119M 102M 96.45M 87.88M 164M 11.21B 165M 1.14B 443M 5.73B 446M 436M 18.83B |
| Net income | -72.06M -62.17M -58.56M -53.36M -99.73M -6.81B -100M -693M -269M -3.48B -271M -265M -11.43B | -48.53M -41.87M -39.44M -35.93M -67.16M -4.58B -67.67M -467M -181M -2.34B -182M -178M -7.7B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 03/09/26 | EUR 6.950 | -4.14% |
| 01/09/26 | EUR 7.250 | +1.40% |
| 31/08/26 | EUR 7.150 | +2.14% |
| 28/08/26 | EUR 7.000 | -7.28% |
| 27/08/26 | EUR 7.550 | +4.14% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
Select your edition
All financial news and data tailored to specific country editions
